Fahr's Disease and Hypoparathyroidism - A Missing Link

Area of Science:

• Neurology
• Radiology
• Endocrinology

Background:

• Fahr's disease is characterized by idiopathic basal ganglia calcification with autosomal dominant inheritance.
• Computed tomography (CT) and magnetic resonance imaging (MRI) are key diagnostic tools for basal ganglia calcification.

Purpose of the Study:

• To emphasize the importance of differentiating Fahr's disease from hypoparathyroidism (HP) and pseudohypoparathyroidism (PHP).
• To highlight the distinct therapeutic approaches required for Fahr's disease versus HP/PHP-related hypocalcemia.

Main Methods:

• Review of diagnostic criteria for Fahr's disease using neuroimaging (CT/MRI).
• Differential diagnosis considerations including endocrine disorders like HP and PHP.
• Comparison of treatment strategies for Fahr's disease and HP/PHP-induced hypocalcemia.

Main Results:

• Imaging findings suggestive of basal ganglia calcification necessitate ruling out HP and PHP.
• HP and PHP can present with hypocalcemia, requiring long-term calcium, calcitriol, and vitamin D therapy to prevent seizures.
• Fahr's disease, once diagnosed, is managed with antiepileptic medication alone.

Conclusions:

• Accurate differentiation between Fahr's disease and endocrine-related calcifications is critical for appropriate patient management.
• Misdiagnosis can lead to ineffective or incorrect treatments, impacting patient outcomes.
• Distinct treatment protocols for Fahr's disease and HP/PHP-related hypocalcemia underscore the need for thorough etiological investigation.